Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
CFDA to Start 60-Day Approvals for INDs of Oncology Drugs | August 27, 2015
Shenzhen Hepalink Pays $206 Million for Cytovance, a US CMO | August 26, 2015
China's State Council Says CFDA Must Set Deadlines for Drug Approvals | August 20, 2015Roche Pays $425 Million for GeneWEAVE, a Decheng Portfolio Company | August 13, 2015
Xinjiekou Department Store Offers $966 Million for China Cord Blood | August 6, 2015
>> See all top stories...
ChinaBio® in the News